Motley Fool Speculates About Fresenius Purchase of NxStage
Will NxStage stock price volatility affect he sale of NxStage to purchaser Fresenius Medical Care? Time will tell, and revenues are up, but profits are not.
Read the full article » | Posted 06-12-2018
Related Articles
- NIH to Consolidate Websites Under Nine Hubs Posted 09-18-2026
- FDA Warns Fresenius About Leaking PD Solution Bags and Particulates Posted 09-18-2026
- Somatus to Open Maryland Home Dialysis Training Center Posted 09-18-2026
- DaVita and Humana Partner to Care for 10,000 Medicare Advantage Members with CKD Posted 09-18-2026